GeoVax Labs (GOVX) Cash & Equivalents (2010 - 2026)
GeoVax Labs (GOVX) recorded Cash & Equivalents of $3.14 million in Q2 2026, up 1.6% from $3.09 million a year earlier.
Powered by 
Analysis
GeoVax Labs (GOVX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, GeoVax Labs reported Cash & Equivalents of $3.09 million, down 44.0% from FY2024.
- Annual Cash & Equivalents has declined for three straight years, with a five-year compound annual growth rate of -20.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $5.51 million in FY2024 (-14.7%), $6.45 million in FY2023 (-76.6%), $27.61 million in FY2022 (+141.7%) and $11.42 million in FY2021 (+15.6%).
- Quarterly Cash & Equivalents has ranged from $768,859 in Q1 2024 to $34.68 million in Q3 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with growth averaging 119.2%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 867.5% in Q1 2025, against a decline of 96.8% in Q1 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | GeoVax Labs | 1.46 Mn | -12.87 Mn | - | 3.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 5.01 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 7.44 Mn |
| Dec 31, 2024 | 5.51 Mn |
| Sep 30, 2024 | 8.59 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 768,859.00 |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | 12.69 Mn |
| Jun 30, 2023 | 17.79 Mn |
| Mar 31, 2023 | 23.85 Mn |
| Dec 31, 2022 | 27.61 Mn |
| Sep 30, 2022 | 34.68 Mn |
| Jun 30, 2022 | 30.90 Mn |
| Mar 31, 2022 | 16.26 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 18.11 Mn |
| Jun 30, 2021 | 19.54 Mn |
API Access
GeoVax Labs Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();